IQV - IQVIA Holdings - Stock Price & Dividends

IQVIA Holdings Inc. is a leading provider of innovative solutions and services to the life sciences industry, operating across the Americas, Europe, Africa, and the Asia-Pacific regions.

The company's Technology & Analytics Solutions segment offers a suite of cloud-based applications, implementation services, and strategic consulting to help life sciences and healthcare providers make informed decisions. This includes generating and disseminating evidence-based insights to improve patient outcomes, as well as providing country-level performance metrics on pharmaceutical sales, prescribing trends, and medical treatment. The segment also offers advanced analytics and commercial process outsourcing services to help clients optimize their operations.

The Research & Development Solutions segment provides a range of services to support clinical trials, including project management, clinical monitoring, and strategic planning. This segment also offers patient-centric and site-centric solutions, as well as laboratory services such as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services.

The Contract Sales & Medical Solutions segment focuses on healthcare provider and patient engagement services, as well as scientific strategy and medical affairs services. This segment helps clients develop and execute effective sales and marketing strategies to reach healthcare providers and patients.

IQVIA Holdings Inc. serves a diverse range of clients, including pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaborative partnership with argenx SE and is headquartered in Durham, North Carolina. With a strong commitment to innovation and customer-centricity, IQVIA Holdings Inc. is well-positioned to drive growth and improvement in the life sciences industry.

For more information, please visit the company's website at https://www.iqvia.com.